The Medtronic-backed medical device developer has filed for an $80m IPO, after raising almost $90m in earlier funding.

The Ascension Health-backed ophthalmic treatment developer will use the proceeds to advance its lead product through Phase 2 and 3 clinical trials.

The financial services data company's initial public offering saw Bank of America, Goldman Sachs, Deutsche Bank and JP Morgan Chase all realise partial exits.

Convergence Pharmaceuticals, spun out of GlaxoSmithKline, which still holds an 18% stake, is considering both London and New York for its initial public offering.

The Wells Fargo-backed mobile device management firm could see the size of the initial public offering increase to $115m before it closes.

The high-definition camera maker's initial public offering, which could value it at up to $3bn, will see shareholders Foxconn and Steamboat Ventures both divest shares.

The flotation is likely to value the company at more than $600m.

The pharmaceutical company has set the range for its initial public offering, which will see Johnson & Johnson become a notable shareholder.

The Amgen-backed biopharmaceutical company is set to generate up to $54m from its initial public offering, after pulling in $59.5m in equity funding since its formation.

The Superconductor Technologies-backed radio frequency technology developer has secured $16.2m in its initial public offering.